Pharmasages may fda approvals
MERCK: ZONTIVITY (VORAPAXAR SULFATE) is a protease-activated receptor-1 (PAR-1) antagonist indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD). ZONTIVITY has been shown to reduce the rate of a combined endpoint of cardiovascular death, MI, stroke, and urgent coronary revascularization. DURATA THERAPEUTICS: DALVANCE (DALBAVANCIN HYDROCHLORIDE) is indicated for acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible strains of Gram-positive microorganisms. TAKEDA PHARMS USA: ENTYVIO is an integrin receptor antagonist indicated for Adult Ulcerative Colitis (UC) and Adult Crohn's Disease (CD). New formulation or new manufacturer of EPANOVA (OMEGA 3 CARBOXYLIC ACIDS) from ASTRAZENECA,IZBA (TRAVOPROST) from ALCON LABS, and NATESTO (TESTOSTERONE) from TRIMEL BIOPHARMA were approved.
Recomendados
Recomendados
Mais conteúdo relacionado
Último
Último (20)
Destaque
Destaque (20)
Pharmasages may fda approvals
- 1. PharmaSages_May FDA Approvals MERCK: ZONTIVITY (VORAPAXAR SULFATE) is a protease-activated receptor-1 (PAR-1) antagonist indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD). ZONTIVITY has been shown to reduce the rate of a combined endpoint of cardiovascular death, MI, stroke, and urgent coronary revascularization. DURATA THERAPEUTICS: DALVANCE (DALBAVANCIN HYDROCHLORIDE) is indicated for acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible strains of Gram-positive microorganisms. TAKEDA PHARMS USA: ENTYVIO is an integrin receptor antagonist indicated for Adult Ulcerative Colitis (UC) and Adult Crohn's Disease (CD). New formulation or new manufacturer of EPANOVA (OMEGA 3 CARBOXYLIC ACIDS) from ASTRAZENECA,IZBA (TRAVOPROST) from ALCON LABS, and NATESTO (TESTOSTERONE) from TRIMEL BIOPHARMA were approved.
- 2. Contact us Ajay Shrivastava, CEO PharmaSages 58 Magnolia Lane Princeton, NJ 08540 Phone: (609)423-7602 E-mail:asbiopro@pharmasages.com Web: www.pharmasages.com